These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 12472324)

  • 1. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
    Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
    JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial.
    Corwin HL; Gettinger A; Rodriguez RM; Pearl RG; Gubler KD; Enny C; Colton T; Corwin MJ
    Crit Care Med; 1999 Nov; 27(11):2346-50. PubMed ID: 10579246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of epoetin alfa in critically ill patients.
    Corwin HL; Gettinger A; Fabian TC; May A; Pearl RG; Heard S; An R; Bowers PJ; Burton P; Klausner MA; Corwin MJ;
    N Engl J Med; 2007 Sep; 357(10):965-76. PubMed ID: 17804841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.
    Kaufner L; von Heymann C; Henkelmann A; Pace NL; Weibel S; Kranke P; Meerpohl JJ; Gill R
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012451. PubMed ID: 32790892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
    Voils SA; Harpe SH; Brophy GM
    Pharmacotherapy; 2007 Apr; 27(4):535-41. PubMed ID: 17381380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients.
    MacLaren R; Sullivan PW
    Value Health; 2005; 8(2):105-16. PubMed ID: 15804319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia and blood transfusion in the critically ill patient: role of erythropoietin.
    Corwin HL
    Crit Care; 2004; 8 Suppl 2(Suppl 2):S42-4. PubMed ID: 15196323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.
    Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Abraham E; MacIntyre NR; Shabot MM; Duh MS; Shapiro MJ
    Crit Care Med; 2004 Jan; 32(1):39-52. PubMed ID: 14707558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit.
    Brophy GM; Sheehan V; Shapiro MJ; Lottenberg L; Scarlata D; Audhya P;
    Clin Ther; 2008 Dec; 30(12):2324-34. PubMed ID: 19167591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
    Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
    Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia and blood transfusion in critically ill patients.
    Vincent JL; Baron JF; Reinhart K; Gattinoni L; Thijs L; Webb A; Meier-Hellmann A; Nollet G; Peres-Bota D;
    JAMA; 2002 Sep; 288(12):1499-507. PubMed ID: 12243637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up.
    Walsh TS; Stanworth S; Boyd J; Hope D; Hemmatapour S; Burrows H; Campbell H; Pizzo E; Swart N; Morris S
    Health Technol Assess; 2017 Oct; 21(62):1-118. PubMed ID: 29067906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternatives to blood product transfusion in the critically ill: erythropoietin.
    Stubbs JR
    Crit Care Med; 2006 May; 34(5 Suppl):S160-9. PubMed ID: 16617261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
    Holst LB
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317].
    Georgopoulos D; Matamis D; Routsi C; Michalopoulos A; Maggina N; Dimopoulos G; Zakynthinos E; Nakos G; Thomopoulos G; Mandragos K; Maniatis A;
    Crit Care; 2005 Oct; 9(5):R508-15. PubMed ID: 16277712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.
    Zarychanski R; Turgeon AF; McIntyre L; Fergusson DA
    CMAJ; 2007 Sep; 177(7):725-34. PubMed ID: 17823140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell transfusion and increased length of storage are not associated with deep vein thrombosis in medical and surgical critically ill patients: a prospective observational cohort study.
    Katsios C; Griffith L; Spinella P; Lacroix J; Crowther M; Hebert P; Meade M; Geerts W; Rabbat C; Cook D
    Crit Care; 2011; 15(6):R263. PubMed ID: 22044745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of exogenous erythropoietin in critically ill patients.
    MacLaren R; Gasper J; Jung R; Vandivier RW
    J Clin Pharm Ther; 2004 Jun; 29(3):195-208. PubMed ID: 15153081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
    Link H; Boogaerts MA; Fauser AA; Slavin S; Reiffers J; Gorin NC; Carella AM; Mandelli F; Burdach S; Ferrant A
    Blood; 1994 Nov; 84(10):3327-35. PubMed ID: 7949088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.